Overview
Type 2A juvenile hereditary hemochromatosis is a genetic disorder characterized by iron overload, typically due to mutations in the HJV (hemojuvelin) gene, leading to early-onset symptoms often before age 30 2.Diagnosis
Genetic Testing: Mutation analysis focusing on HFE genes; however, for Type 2A, HJV gene testing is crucial 1.
Biochemical Markers: Elevated transferrin saturation and serum ferritin levels 2.
Histological Confirmation: Liver biopsy showing iron overload and meeting specific hepatic iron index criteria 2.Management
Prophylactic Phlebotomy: Primary treatment to reduce iron stores 1.
Regular Monitoring: Frequent assessment of iron parameters to guide phlebotomy frequency 1.
Dietary Modifications: Avoidance of iron-rich foods and supplements not typically specified but recommended in broader HH management 1.Special Populations
Pediatrics: Early diagnosis and intervention crucial; specific pediatric dosing or considerations not detailed in provided abstracts 2.
Comorbidities: Management should address coexisting conditions; specific guidance lacking in abstracts 1.Key Recommendations
Utilize HFE mutation analysis and extend to HJV testing for definitive diagnosis in suspected Type 2A juvenile hereditary hemochromatosis (Evidence: Moderate 1).
Implement prophylactic phlebotomy in identified cases to prevent organ damage (Evidence: Expert opinion 1).
Screen high-risk populations, particularly those with Celtic ancestry, for early detection (Evidence: Moderate 2).References
1 Kohli M, Schichman SA, Fink L, Zent CS. Use of HFE mutation analysis for hereditary hemochromatosis: the need for physician education in the translation of basic science to clinical practice. Southern medical journal 2000. link
2 Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubo R et al.. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor?. Hepatology (Baltimore, Md.) 1997. link